Follow the 시지메드텍 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 시지메드텍 has recorded 80 insider filings. The latest transaction was disclosed on 19 January 2026 (Purchase). Among the most active insiders: 시지바이오. The full history is free.
79
Insider Decl.
n/a
Thresholds
n/a
44 ops.
Buy Volume
n/a
1 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
시지메드텍 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in the development of innovative medical technologies.